GlaxoSmithKline Pharmaceuticals informs about clarification

04 Aug 2025 Evaluate
GlaxoSmithKline Pharmaceuticals has informed that in reference to the communications dated August 1, 2025 received from National Stock Exchange of India, bearing reference number: NSE/CM/Surveillance/15703, and from BSE Limited, bearing reference number: L/SURV/ONL/RV/AJ/ (2025-2026)/ 54, seeking clarification regarding the news article published on https://www.moneycontrol.com on August 1, 2025, titled 'Trump Tariff News Live: GSK and AstraZeneca among top companies told to 'cut US prices or else'. At the outset, it is clarified that the said news item does not pertain to GlaxoSmithKline Pharmaceuticals (the Company). Instead, it concerns GSK plc (previously GlaxoSmithKline plc), our ultimate parent company in the United Kingdom. The Company does not have any further information regarding the events stated in the said article and is therefore unable to comment on any material impact of the same on the Company. The Company is also not aware of any information or announcement, including any pending announcement, which in the Company’s opinion, could have a bearing on the share price of the Company. Accordingly, at present, the Company does not have any information concerning the events stated in the said article which is disclosable in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2464.90 -19.80 (-0.80%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×